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In this report the synthesis, characterization, and functional evaluation of a multimodal nanoparticulate
contrast agent for noninvasive imaging through both magnetic resonance imaging (MRI) and photoacoustic
tomography (PAT) is presented. The nanoparticles described herein enable high resolution and highly
sensitive three-dimensional diagnostic imaging through the synergistic coupling of MRI and PAT
capabilities. Gadolinium (Gd)-doped gold-speckled silica (GSS) nanoparticles, ranging from 50 to 200
nm, have been prepared in a simple one-pot synthesis using nonionic microemulsions. The photoacoustic
signal is generated from a nonuniform, discontinuous gold nanodomains speckled across the silica surface,
whereas the MR contrast is provided through Gd incorporated in the silica matrix. The presence of a
discontinuous speckled surface, as opposed to a continuous gold shell, allows sufﬁcient bulk water exchange
with the Gd ions to generate a strong MR contrast. The dual imaging capabilities of the particles have
been demonstrated through in silicio and in Vitro methods. The described particles also have the capacity
for therapeutic applications including the thermal ablation of tumors through the absorption of irradiated
light.
Introduction
One of the important promises of nanotechnology is the
development of techniques and tools for cancer diagnosis
using safe, noninvasive, low-cost means with high resolution
and sensitivity. Existing clinical imaging modalities, such
as computed tomography, magnetic resonance imaging
(MRI), positron emission tomography, and ultrasound, differ
from one another in terms of detection sensitivity, spatial-
temporal resolution, signal-to-noise ratio, quantitative ac-
curacy, and long-term safety.
1,2 None of these methods are
capable of providing complete structural and functional
information independently.
3 Hence, it is often desirable to
employ information from complimentary imaging modalities
to enhance prognosis and enable early and accurate detection
of tumors.
3,4 The need for complimentary diagnostic infor-
mation has led to the emergence of multimodal contrast
agents that are capable of generating contrast by different
modalities, simultaneously.
MRI, a common clinical imaging modality, has the
capability of constructing three-dimensional (3D) images of
biological structures providing high anatomical details. High
dosages of commercial Gd-based MR contrast agents are
commonly used to improve image resolution. However, these
contrast agents, by themselves, are not sensitive enough to
obtain images that can be resolved at the single-cell level.
Single-cell MRI capability will allow for early disease
diagnosis, stem cell tracking, gene and drug delivery, etc.
Therefore, the development of high-resolution image contrast
agents such as nanoparticle-based MRI contrast agents has
a great demand.
Photoacoustic tomography (PAT, also known as laser
optoacoustic or thermoacoustic imaging) is an emerging
noninvasive, nonionizing, deeply penetrating imaging
modality
5,6 that combines the advantages of the sensitivity
of optical methods with the resolution of diffraction-limited
ultrasound. In PAT, a nonionizing short-pulsed optical laser
is used as an excitation source to generate an acoustic signal
resulting from thermoelastic expansion of the absorbent
which is then detected and used to recover the geometry of
the object. PAT has been used to image tumors,
7,8 blood
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in the absence and presence of contrast agents.
12-14 PAT
provides femtomolar sensitivity and high temporal and spatial
resolution.
7,9,15,16 It would be advantageous to obtain simul-
taneous structural and functional information with high
resolution using a multimodal image contrast agent for
noninvasive imaging by both PAT and MRI.
In this paper we report a novel multimodal nanoparticle
that provides the ﬁrst example of a single-nanoparticle
contrast agent for noninvasive imaging by both PAT and
MRI. The use of MRI, a well-established imaging method,
in parallel with PAT (made possible through the use of these
nanoparticles) is expected to enable rapid enhancement and
further development of improved computational algorithms
for PAT image constructionsenhancing the breath and
capabilities of the method. PAT may potentially prove useful
for patients with cardiac pacemakers, certain metallic im-
plants, or metallic debris (e.g., shrapnel, iron ﬁlings) in their
body that are precluded from undergoing MRI scans due to
strong magnetic ﬁelds. Although PAT currently does not
provide the magnitude of anatomical information afforded
by MRI, it can provide 3D deep tissue imagery that is
comparable to MRIsparticularly in the presence of contrast
agents.
9,15,17 MRI-PAT bimodal contrast agents may also
be used for clinical prescreening purposes to lower the burden
on existing MRI facilities and provide a low-cost, nonion-
izing method for the analysis of soft tissue. Multimodal
MRI-PAT nanoparticles are also envisaged to be potentially
useful for diagnostic imaging and therapy of cancer. Because
the generation of acoustic signal is due to the thermoelastic
expansion of the PAT contrast agents, it is possible to elevate
the temperature of the target tissue by increasing the intensity
of the incident laser beam, causing signiﬁcant damage to
tumor tissue. Thus, the development of safer, nonionizing
diagnostic methods would enable implementation of ad-
vanced bioimaging solutions for larger spectrum of patients
that can be applied in the ﬁeld, in common clinics, as well
as in major hospitals and medical institutions.
Materials and Methods
Materials. Tetraethylorthosilicate (TEOS), Triton X-100 (TX-
100), n-hexanol, 3-(aminopropyl)triethoxysilane (APTS), and cy-
clohexane were purchased from Aldrich Chemical Co. Inc. N-(Tri-
methoxysilyl-propyl)ethyldiaminetriacetic acid trisodium salt
(TSPETE) (45% wt % solution in water) was purchased from Gelest
Co., gold chloride, gadolinium acetate, and hydrazine hydrate were
obtained from Acros Organics, and ammonium hydroxide (NH4OH,
28-30 wt %) was obtained from the Fisher Scientiﬁc Co. All other
chemicals were of analytical reagent grade. Deionized (DI) water
(NANOpure, Barnstead) was used for the preparation of all
solutions.
Methods. Synthesis of Gd-Doped GSS Nanoparticles. The
complete synthesis of the multimodal nanoparticles was done in
one pot using reverse micelles. The water-in-oil (W/O) microemul-
sion was prepared by mixing TX-100 cyclohexane, n-hexanol (1:
4.2:1 v/v), and appropriate water. n-Hexanol was used as a
cosurfactant to the nonionic surfactant, TX-100. An amount of 0.050
mL of TEOS was added in the beginning to the microemulsion
and allowed to equilibrate for 30 min. The hydrolysis and
polymerization of TEOS was then initiated by adding 0.05-0.200
mL of NH4OH. The overall W0 (water to surfactant molar ratio)
after addition of NH4OH was 10. After allowing silica polymeri-
zation reaction to go for 24 h, the surface of the silica nanoparticle
was modiﬁed with the addition of 0.025 mL of TSPETE and 0.050
mL of TEOS. The resulting solution was allowed to stir overnight.
This was followed by the addition of 0.10 mL of 0.1 M Gd(III)
acetate solution and stirring for another 4 h. This was followed by
addition of 0.5 mL of 0.25 M HAuCl4, prepared in degassed water,
and 1.1 M solution of reducing agent (hydrazine hydrate). The
solution was allowed to stir for ∼12 h. The progress of the reaction
at each step was monitored by UV-vis absorption spectroscopy.
The Gd-doped GSS nanoparticles were then isolated from the
microemulsion by adding 5 mL of 200 proof ethanol. The solution
was then stirred for a few minutes. This led to the complete
breakdown of reverse micelles with the formation of two immiscible
layers of aqueous ethanol and cyclohexane. The nanoparticles along
with the surfactant molecules were accumulated in bottom ethanol
layer. The top layer of cyclohexane was carefully removed, and
the particles were centrifuged. The particles were washed three times
with ethanol and ﬁve times with water in order to completely
remove surfactant molecules. Each centrifugation step, during
washing was followed by vortexing and sonication to redisperse
the pelleted particles. After complete removal of surfactant the
particles were redispersed in Nanopure water to obtain a concentra-
tion of ca. 2 mg/mL for further characterization.
Particle Size Measurements. The particle size and distribution
were measured by dynamic light scattering (DLS) using a Microtrac
NANOTRAC and CPS disk centrifuge. The size and morphology
of the particles were determined by transmission electron micros-
copy (TEM). TEM and energy-dispersive X-ray spectroscopy (EDS)
spectra of the particles were done using JEOL 2010F transmission
electron microscope.
InductiVely Coupled Plasma Experiments. Inductively coupled
plasma (ICP) measurements were performed using a Perkin-Elmer
Plasma 3200 system equipped with two monochromators covering
the spectral range of 165-785 nm with a grated ruling of 3600
lines/mm. Brieﬂy, 0.050 g of the nanoparticle sample was digested
using aqua regia solution. [Caution: Aqua regia digestion should
be performed with care in a hood. Its reaction with GSS nanopar-
ticles produces acrid and toxic fumes.] Au and Gd were completely
solubilized in the aqua regia, whereas the silica matrix was settled
at the bottom of the container as a white powder. After complete
digestion the solution was ﬁltered to separate the silica particles as
residue. The particles were washed three times with aqua regia
solution and ﬁnally twice with nanopure water. The ﬁltrate and
the particles were all collected together and boiled to concentrate
the volume to 15.0 mL. After instrument calibration was performed
for Au and Gd estimation, the ﬁltrate was analyzed by ICP for
quantitative estimation of Gd and Au.
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measurements were recorded using a 4.7 T Bruker Avance MR
scanner. Phantom preparation for MR relaxivity measurements was
done by serially diluting a 10 mg/mL stock solution of Gd-doped
GSS nanoparticles with ddH2O and mixing with a 1% agarose
solution (Ultra-Pure agarose, Invitrogen, Carlsbad, CA) yielding a
ﬁnal concentration of 0.5% agarose. The resulting nanoparticle
concentrations of 5, 2.5, 1.25, 0.625, and 0.3125 mg/mL were then
injected into 100 µL capillary tubes (Curtin-Matheson Scientiﬁc,
Broomall, PA) and allowed to solidify on ice, thereby eliminating
sedimentation during relaxivity measurements. The comparison of
MR response between Gd-doped GSS nanoparticles and silica
nanoparticles (without any gold or Gd) was performed similarly
by diluting 10 mg/mL nanoparticles in 1% agarose solution
(Supporting Information). Control phantoms containing just 0.5%
and 1% agarose were simultaneously imaged to determine effect
of agarose on relaxation times. Right before imaging, all samples
were placed together inside a water-ﬁlled FACS tube (BD Falcon,
Franklin Lakes, NJ) to avoid susceptibility artifacts from the
surrounding air.
MR RelaxiVity for Gd-Doped GSS Nanoparticles. All relaxivity
data were analyzed using Paravision software (PV3.02; Bruker
Medical). For measuring T1 relaxation times, axial spin-echo (SE)
scan sequences were obtained with TE ) 4.5 ms, matrix size )
128 × 128, FOV ) 2.8 × 2.8 cm
2, spectral width ) 180 kHz, one
average, 1 mm slice thickness, and varying TR values of 11, 6, 3,
1.5, 0.75, 0.5, 0.25, 0.125, 0.075, 0.05, 0.025, and 0.015 s. For T2
relaxation measurements, axial T2-weighted single-slice multiecho
images were obtained with TR ) 11 s, TE ) 5m s∆TE ) 5m s
(60 echoes), matrix size ) 128 × 128, FOV ) 2.8 × 2.8 cm
2,
spectral width ) 100 kHz, two signal averages, anda1m mslice
thickness. T1 and T2 maps were calculated assuming a monoexpo-
nential signal decay and by using a nonlinear function, least-squares
curve ﬁtting on the relationship between changes in mean signal
intensity within a region of interest (ROI) to TR and TE. T1 and T2
relaxation times(s) for the Gd-doped GSS nanoparticles in 0.5%
agarose were then derived by ROI measurements of the test samples
converted into R1 and R2 relaxation rates (1/T1,2 (s
-1)). Finally,
R1,2 values were plotted against the concentration of Gd on the
nanoparticle and r1 and r2 (mM
-1 s
-1) relaxivities were obtained
as the slope of the resulting linear plot.
T2* relaxivity measurements were acquired by T2*-weighted
FLASH gradient echo scan sequences. TRs were kept constant at
500 ms with varying TEs of 4, 8, 12, 16, 20, 40, 60, and 100 ms,
FOV ) 2.8 × 2.8 cm
2, matrix size ) 256 × 256, two signal
averages, spectral width ) 60 kHz, and 1 mm slice thickness. Image
J software (NIH) with an MR analysis calculator plug-in was used
to quantify T2* values by stacking the individual FLASH sequences
with varying TEs and creating a T2* map. ROIs for each cell sample
were then drawn to contain the entire cross section of each of the
samples, and values were then plotted as R2* (or the inverse of
T2* (1/T2*, (s
-1))), against the concentration of Gd in the sample
(Excel, Microsoft Inc.). R2* relaxivity (mM
-1 s
-1) was later
obtained as the slope of the resulting linear plot. Data are presented
as the mean ( SD of measurements.
PAT Instrumentation. A mechanical scanning photoacoustic
system with single acoustic transducer to collect the acoustic signals
was utilized. A schematic representation of the PAT experimental
setup is shown in the Supporting Information. A pulsed Nd:YAG
laser (Altos, Bozeman, MT) working at 532 nm with 4 ns pulse
duration, 10 Hz repetition rate and 360 mJ maximum pulse power
acted as light source. The diameter of laser beam was expanded to
30 mm by a lens. An immersion acoustic transducer with 1 MHz
nominal frequency (Valpey Fisher, Hopkinton, MA) was driven
by a motorized rotator to receive acoustic signals over 360° for
phantoms at an interval of 3°, and thus a total of 120 measurements
were performed for one planar scanning. The scanning plane could
be adjusted along the z-axis by mounting the rotator and the
transducer on a platform driven by a linear stage. The acoustic
transducer was immersed into the water tank while the phantom
was placed at the center of the tank where it was illuminated by
the laser. The complex wave ﬁeld signal was ampliﬁed by a pulser/
receiver (GE Panametrics, Waltham, MA) and then acquired by a
high-speed PCI data acquisition board. PAT images were recon-
structed by our reconstruction algorithm that is based on the ﬁnite
element solution to the photoacoustic wave equation in the
frequency domain, which can provide stable inverse solutions.
18
Phantoms for imaging were constructed using intralipid, India ink,
distilled water, and 2% agar powder as described previously.
19 The
diameters of all phantoms used in this study were 25 mm. The
absorption and reduced scattering coefﬁcients (optical properties)
of these phantoms were 0.007 and 0.5 mm
-1, respectively.
Nanoparticles were embedded in the phantom at a depth of 2 mm
for imaging.
Macrophage Labeling and Phantom Preparation for MRI and
PAT. Mouse monocyte/macrophage J774 cells were defrosted,
resuspended in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
(GIBCO, Grand Island, NY) supplemented with 10% fetal bovine
serum (Summit Biotechnology, Ft. Collins, CO), 1% glutamax
(GIBCO), 1% penicillin/streptomycin (GIBCO), and incubated at
a density of 5 × 10
5 cells/mL in 100 mm culture dishes at 37 °C
and 5% CO2. Media was replaced 24 h after plating, and the cells
were allowed to attach and grow to conﬂuency (usually within 2-3
days). Old media was replaced with fresh before the cells were
harvested and washed twice by spinning them down at 1100 rpm
for 5 min using a Sorvall RT7 plus ultracentrifuge and resuspending
in fresh DMEM complete media. Cells were subsequently replated
at a density of 2 × 10
5 and again allowed to attach and grow to
conﬂuency. Cells were passaged for 3-4 times before the start of
the labeling experiment. During labeling, 1 × 10
6 freshly split J774
cells/mL DMEM complete were incubated overnight with 100 µg/
mL of Gd-doped GSS nanoparticles in a six-well tissue culture dish.
The next day label-containing media was aspirated off and replaced
by fresh media before labeled and unlabeled control cells were
scraped up, washed twice in ice-cold Dulbecco’s phosphate-buffered
saline (DPBS) (GIBCO, Grand Island, NY), counted, and resus-
pended at a density of 3.33 × 10
7 cells/mL each in DPBS (2 ×
10
6 cells in 60 µL DPBS). Cells were kept on ice until the time of
imaging when 20 µL of cell suspension was then injected in the
phantom. The same phantom was used for MRI and PAT experi-
ments in succession.
MRI Measurements on J774 Cells Labeled with Gd-Doped
GSS Nanoparticles. The sample phantom containing GSS-labeled
J774 and control cells was placed inside a solenoid coil and imaged
at 4.7 T magnetic ﬁeld strength. T1- and T2-weighted SE scan
sequences were used to detect Gd on the nanoparticles inside the
cells. For generating T1-weighted images a multislice multiecho
(MSME) pulse sequence was used with TR ) 500 ms, TE ) 5
ms, matrix size ) 256 × 256, FOV ) 3 × 3c m
2, spectral width
) 100 kHz, two signal averages, anda1m mslice thickness. T2-
weighted images was acquired either by using a MSME pulse
sequence with TR ) 500 ms, TE ) 100 ms, matrix size ) 256 ×
256, FOV ) 3 × 3c m
2, spectral width ) 100 kHz, two signal
averages, anda1m mslice thickness or by using a rapid acquisition
with relaxation enhancement (RARE) pulse sequence with TR )
(18) Yuan, Z.; Wu, C. F.; Zhao, H. Z.; Jiang, H. B. Opt. Lett. 2005, 30,
3054.
(19) Tam, A. C. ReV. Mod. Phys. 1986, 58, 381.
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cm
2, spectral width ) 60 kHz, four signal averages, RARE factor
) 8 ,a n da1m mslice thickness.
Results and Discussion
Existing contrast agents for PAT include near-IR absorbing
dyes and gold-based nanomaterials,
12,17,20 which have been
demonstrated for various therapeutic and imaging applica-
tions.
21-26 Although the possibility of using gold nanoshells
as exogenous PAT contrast agent has been described,
27 only
a few experimental reports exist in the literature.
14 Similarly,
the application of molecular dyes in PAT has been limited
due to their poor in ViVo stability and rapid clearance from
the biological systems.
28 Although gold nanoshells exhibit
the desired optical and photothermal properties for PAT, the
need for a continuous shell of up to 20 nm in thickness
(resulting in an overall particle size of 120-150 nm
21,27,29)
limits their capacity to internally integrate MRI contrast
through the restriction of water exchange. Moreover, their
larger size (>120 nm) could limit certain bioimaging
applications such as tracking stem cells, viruses, etc., where
size tunability, in particular, smaller particle size, is preferred.
To overcome the size restrictions of existing gold nanoshell
particles as well as introduce the property of being multi-
modal contrast agents, we have developed a gold-silica
hybrid material termed gold-speckled silica (GSS) nanopar-
ticles. These MRI-PAT-active multimodal nanoparticles
have a surface layer composed of discontinuous, irregular
gold nanodomains of varying crystallinity that are incorpo-
rated within the pores and on the exterior of the supporting
silica matrix. The multitude of dielectric-metal interfaces
created by this method gives rise to unique photothermal
properties that enable the use of these materials as contrast
agents in PAT. Gd incorporated in the silica matrix of the
nanoparticles provides MRI contrast. These multimodal GSS
nanoparticles possess high MRI relaxivity and at the same
time produce a strong PAT contrast.
The complete synthesis of the multimodal GSS nanopar-
ticles has been carried out in one pot using the nonionic W/O
microemulsion method. The synthesis procedure for these
nanoparticles has been described in detail in the Materials
and Methods. Brieﬂy, Gd-doped silica nanoparticles are ﬁrst
formed by cocondensation of TEOS and a silane reagent that
strongly chelates polyvalent metal ions
30-34 (TSPETE) in
the water core of the TX-100/n-hexanol/water W/O micro-
emulsion. Incorporation of chloroauric acid followed by its
reduction was the carried out within the surface layer of the
silica nanoparticles. By manipulating W0 of the microemul-
sions and the reactant concentrations, we were able to tune
Gd-doped GSS nanoparticle size from less than 50 to 200
nm. Parts A and B of Figure 1 show representative TEM
micrographs for two different samples prepared at W0 10
and 14, depicting mean particle size of ∼100 ((10) and 55
((5) nm, respectively. GSS nanoparticles up to 200 nm and
larger were synthesized at W0 5 (Supporting Information)
using the same microemulsion system. The particle sizes
were conﬁrmed using DLS and disk centrifuge techniques.
A key difference between the current particles and those
previously described in the literature lies in the nature of
the gold nanoparticle generation and deposition on and in
the silica matrix. In a traditional synthesis route (seed-
mediated synthesis), 1-2 nm uniform gold nanoparticles are
ﬁrst deposited on the silica surface as small clusters. In the
following step, gold nanoshell is created by allowing further
deposition and growth of these gold clusters. The shell
thickness of the gold nanoshells can vary between 1-20 nm.
Unlike the traditional approach of depositing gold nano-
particles
21,27 onto silica nanoparticles, we incubated Gd-
doped silica nanoparticle within the aqueous core of the
microemulsion with chloroauric acid, allowing gold ions to
permeate further into the mesoporous silica matrix. Upon
reduction a unique gold-speckled surface results due to the
deposition of the gold nanodomains. Via this method
discontinuous, randomly deposited, sometimes templated, and
often irregular gold nanoclusters are formed within and on
the surface of the silica core. High-resolution TEM (HR-
TEM) micrographs of ∼100 nm Gd-doped GSS nanoparticles
(prepared at W0 ) 10) demonstrate speckled surface deposits
of gold, as seen in areas of darker contrast on the silica
surface (Figure 1C) and as areas of lighter contrast in the
dark-ﬁeld TEM picture (Figure 1D). Note that Gd doping
also contributes to the background as a darker and lighter
haze in Figure 1, parts C and D, respectively. The HRTEM
micrograph (Figure 2) shows scattered deposition of gold
nanoparticles ranging from less than 1 to 5 nm, with varying
crystallinity, on the silica surface. These random and irregular
clustered deposits, which include templated deposits within
the mesopores, make this class of particles distinct and
provide for their unique optical properties such as efﬁcient
photothermal properties. Since these particles were also
doped with Gd ionssa paramagnetic species that affects the
longitudinal relaxation rate of watersthey exhibited MRI
contrast.
(20) Yang, X.; Skrabalak, S. E.; Li, Z. Y.; Xia, Y.; Wang, L. V. Nano
Lett. 2007, 7, 3798.
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(23) Liu, Z. X.; Song, H. W.; Yu, L. X.; Yang, L. M. Appl. Phys. Lett.
2005, 86, 113109.
(24) Park, H. Y.; Schadt, M. J.; Wang, L.; Lim, I. I.; Njoki, P. N.; Kim,
S. H.; Jang, M. Y.; Luo, J.; Zhong, C. J. Langmuir 2007, 23, 9050.
(25) Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera,
B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Proc. Natl.
Acad. Sci. U.S.A. 2003, 100, 13549.
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5, 709.
(27) Hirsch, L. R.; Gobin, A. M.; Lowery, A. R.; Tam, F.; Drezek, R. A.;
Halas, N. J.; West, J. L. Ann. Biomed. Eng. 2006, 34, 15.
(28) Kim, G.; Huang, S. W.; Day, K. C.; O’Donnell, M.; Agayan, R. R.;
Day, M. A.; Kopelman, R.; Ashkenazi, S. J. Biomed. Opt. 2007, 12,
044020.
(29) Oldenburg, S. J.; Westcott, S. L.; Averitt, R. D.; Halas, N. J. J. Chem.
Phys. 1999, 111, 4729.
(30) Bringley, J. F.; Lerat, Y. J. United States Patent Applications 2004-
868626, 2005276862, AN 2005:1311129, 2005.
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States Patent Applications 2004-936910, 2005226913, AN 2005:
1103187, 2005.
(32) Bronstein, L. M.; Linton, C. N.; Stein, B. D.; Dixit, S.; Svergun, D. I.
Abstr. Pap.sAm. Chem. Soc. 2004, 228, U501.
(33) Santra, S.; Bagwe, R. P.; Dutta, D.; Stanley, J. T.; Walter, G. A.;
Tan, W.; Moudgil, B. M.; Mericle, R. A. AdV. Mater. 2005, 17, 2165.
(34) Yang, H. S.; Santra, S.; Walter, G. A.; Holloway, P. H. AdV. Mater.
2006, 18, 2890.
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particles particles was determined using EDS and ICP
techniques. A representative line scan (Figure 3A) and
composite EDS spectrum (Figure 3B) showed the spectral
counts corresponding to Si, O, Au, Gd, and the overall
spectrum for the nanoparticle, respectively. The elemental
composition as determined by ICP gave average number of
atoms of Au and Gd to be ∼426 200 and ∼34 000 per
nanoparticle, respectively. Theoretical calculations showed
that ∼72 times more number of gold atoms would be present
in a single gold nanoparticle of similar dimension. To our
knowledge, this is the ﬁrst report of one-pot synthesis of
Gd-doped GSS nanoparticulate contrast agents as well as
the ﬁrst example of a multimodal contrast agent for MRI
and PAT. The evaluation of the MRI and PAT bifunctional
properties of these nanoparticulates has been demonstrated
using agar gel phantoms as described in the following
sections.
The Gd-doped GSS nanoparticles were shown to generate
MR contrast on both T1 and T2 proton relaxation time
weighted sequences as depicted in Figure 4, parts A and B.
Quantitatively, MR contrast is evaluated by estimating the
relaxivity of the nanoparticle. The relaxivity (Ri, i ) 1, 2) is
deﬁned as the gradient of the linear plot of relaxation rates
(1/Ti, i ) 1, 2) versus Gd concentration [Gd],
35 i.e., 1/Ti )
1/To + Ri[Gd], where Ti is the relaxation time for a contrast
Figure 1. (A) Representative TEM picture of Gd-doped GSS nanoparticles, with an average size of ∼100 nm and (B) Gd-doped GSS particles with an
average size of ∼50 nm. (C) High-resolution TEM picture of the nanoparticle showing the presence of electron-dense gold on the silica nanoparticle and (D)
dark-ﬁeld TEM picture showing the contrast from the presence of the electron-dense species.
Figure 2. High-resolution TEM picture of the nanoparticle showing the
lattice planes of gold nanoparticles as deposited on the silica nanoparticle.
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time in the absence of a contrast agent. From the data in
Figure 4C-E, the relaxivities R1, R2, and R2* are determined
to be 13, 110, and 173 mM
-1 s
-1, respectively. When
compared with commercially available contrast agents,
Gd-GSS exhibit much higher relaxivity values under the
same magnetic strength of 4.7 T.
36 In MRI, it is well-
established that the Gd-generated MR contrast relies on the
relaxation process of the water molecules in association with
the Gd ion and those exchanged in the surrounding
environment.
37,38 For an efﬁcient relaxation process, rapid
water exchange between bound (or inner coordination water)
with the bulk water and slow tumbling play an important
role.
37 The Gd-doped GSS nanoparticles address both these
factors. First, the presence of the discontinuous GSS surface
allows sufﬁcient bulk water exchange with the Gd ions
enabling MR tracking ability. It should be noted that a
continuous gold shell over the silica core could limit the
extent of water exchange inhibiting T1 contrast. Second,
tumbling ratesanother important factor for producing an
effective MRI contrastsis also reduced in the Gd-doped GSS
particles through the rigid binding of Gd to the nanoparticle (35) Toth, E.; Bolskar, R. D.; Borel, A.; Gonzalez, G.; Helm, L.; Merbach,
A. E.; Sitharaman, B.; Wilson, L. J. J. Am. Chem. Soc. 2005, 127,
799.
(36) Rohrer, M.; Bauer, H.; Mintorovitch, J.; Requardt, M.; Weinmann,
H. J. InVest. Radiol. 2005, 40, 715.
(37) Aime, S.; Botta, M.; Terreno, E. AdV. Inorg. Chem. 2005, 57, 173.
(38) Caravan, P. Chem. Soc. ReV. 2006, 35, 512.
Figure 3. (A) Line scan of Gd-doped GSS nanoparticle showing the spectral emission from the constituent elements. (B) EDS spectrum of the multimodal
nanoparticles showing the presence of silicon (Si), oxygen (O), gold (Au), and gadolinium (Gd).
Figure 4. Magnetic resonance data and PAT contrast from Gd-doped GSS nanoparticle. (A) T1-weighted (repetition time (TR) ) 11 000 ms, echo time (TE)
) 4.2 ms) and (B) T2*T R) 500 ms, TE ) 40 ms images of serial dilutions of Gd-doped GSS nanoparticle: (a) 0.24, (b) 0.12, (c) 0.06, (d) 0.03, and (e)
0.015 mM of Gd in 0.5% agarose and (f) 0.5% agarose (as control). Linear plots of Gd concentration vs (C) 1/T1, (D) 1/T2, and (E) 1/T2*, respectively, to
obtain ionic relaxivities, R1, R2, and R2*, respectively, of Gd-doped GSS nanoparticle. (F) Comparison of PAT contrast from gold and GSS nanoparticles
of similar size and concentration (8 µL of 10 mg/mL) in a tissue-like phantom with background: absorption coefﬁcient µa ) 0.007 mm
-1 and reduced
scattering coefﬁcient, µs′ ) 0.5 mm
-1. A stronger photo-acoustic signal is obtained from GSS nanoparticles as compared to gold nanoparticles.
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nanoparticles are much slower than free Gd chelates and thus
produce an enhanced relaxation. One of the major limitations
of current molecular chelates used as MR contrast agent is
their low sensitivity; this requires the use of higher dosages
and results in poor targetability.
38 Both these concerns are
also addressed in the present construct. Approximately,
34 000 ions of Gd are captured per nanoparticle with an
average size of 100 nm, which is higher than the number of
Gd ions previously reported in other nanoparticles such as
synthetic polymers (6-70 ions) and in dendrimers (between
5 and 1331 ions, strongly dependent on particle size
39) and
comparable to perﬂuorocarbon nanoparticles (90 000 Gd ions
in 250 nm diameter particle
40).
The ability of Gd-GSS nanoparticles to generate pho-
toacoustic contrast was conﬁrmed by placing the particles
in an agar phantom containing India ink and intralipid to
simulate tissue-like absorption and scattering. Figure 4F
shows the comparison of PAT contrast from GSS nanopar-
ticles and compares it to that of similar size and concentration
of gold nanoparticles. The dark red region in the area of the
nanoparticles, with respect to the blue background, demon-
strates that a strong PAT contrast is observed from the
particles. As shown in Figure 4F the GSS nanoparticles
generated a stronger photoacoustic signal when compared
to the gold nanoparticles. The stronger PAT contrast from
the GSS nanoparticles, in spite of the presence of ∼72-fold
less gold atoms, demonstrates them as a better PAT contrast
agent. Control experiments were also performed using silica
nanoparticles (without gold or Gd) which illustrated that the
bare silica nanoparticles do not have a signiﬁcant PAT
contrast (Supporting Information). Because the PAT origi-
nates from the optical absorption of the illuminating laser
wavelength, the GSS particles also hold therapeutic potential
for the thermal ablation of tumors. Hence, the particles
described here hold both multimodal imaging as well as
therapeutic capabilities.
To evaluate the bimodal character of the GSS nanopar-
ticles, simultaneous MR and photoacoustic evaluation was
carried out. To achieve this, the GSS particles were placed
in tissue-like phantom. The phantom was imaged for PAT
and MR in succession, and the results are shown in Figure
5. An increase in the MR and PAT signal intensity is
observed with increasing particulate amounts.
In vitro studies have also been carried out with the GSS
nanoparticles to assess the functional ability of the particles
in the cellular environment. The uptake of the GSS nano-
particles by J774 macrophages was carried out as explained
in the Materials and Methods. The cells were then placed in
tissue-like phantom and imaged by PAT and MRI in
succession. Figure 6 shows the phantom design with the
sample placement and the MR and PAT images obtained
with the same phantom. It is observed that the cells labeled
with the GSS nanoparticles produce a strong PAT contrast
as compared to the background. The MR image of the same
phantom shows the ability to generate the T1 and T2 contrast.
The in vitro experiments demonstrated the capability of the
GSS nanoparticles to generate an efﬁcient PAT and MR
contrast in living cells, showing potential use of GSS
nanoparticles as in vivo cell tracker.
In summary, we have described the synthesis and sys-
tematic characterization of new MRI- and PAT-active
multimodal nanoparticle-based contrast agents. The nano-
(39) Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Chem. ReV.
1999, 99, 2293.
(40) Morawski, A. M.; Winter, P. M.; Crowder, K. C.; Caruthers, S. D.;
Fuhrhop, R. W.; Scott, M. J.; Robertson, J. D.; Abendschein, D. R.;
Lanza, G. M.; Wickline, S. A. Magn. Reson. Med. 2004, 51, 480.
Figure 5. (A) The PAT and (B) MRI (T1) contrast from the same phantom, using 1, 3, and 5 µL (particle concentration, 10 mg/mL) of Gd-doped GSS using
sample in tissue-like phantom with background absorption coefﬁcient µa ) 0.007 mm
-1 and scattering coefﬁcient, µs′ ) 0.5 mm
-1, demonstrating the
multimodal nature of the nanoparticles.
Figure 6. Panel I shows the position of J 774 macrophage cells labeled
with GSS nanoparticles marked as A, and unlabeled cells B, in the tissue-
like phantom. Panel II shows the PAT image, panel III is the T1-weighted
spin-echo image with TR ) 500 ms, TE ) 6 ms, and panel IV is the
T2-weighted spin-echo image with TR ) 500 ms, TE ) 100 ms.
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where the nanoparticle size was tuned by varying micro-
emulsion parameters such as W0 value and reactant concen-
tration. The composite nanoparticles are composed of a silica
core containing chelated Gd moieties, partially covered with
randomly deposited irregular gold speckles, or nanoclusters.
The speckled surface permits efﬁcient water exchange
between the Gd in the nanoparticle and the bulk water,
resulting in an efﬁcient MR contrast. In addition the particles
also generate an efﬁcient PAT contrast emanating from
metal-dielectric interfaces. These multimodal nanoparticles
have the potential to be used as diagnostic as well as
therapeutic agents.
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